[1] Watanabe-Fukunaga R, Brannan CI, Copeland NG, et al.Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature, 1992,56(6367):314-317. [2] Takahashi T, Tanaka M, Brannan CI, et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell, 1994,76:969-976. [3] Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992,35:630-640. [4] Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V.J Immunol Methods, 1995,184:39-51. [5] Perniok A, Wedekind F, Herrmann M, et al. High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus, 1998,7:113-118. [6] 金欧,孙凌云,张杏书.系统性红斑狼疮患者外周血淋巴细胞早期凋亡的研究.中华风湿病学杂志,1998,2:200-203. [7] 石成钢,尹培达,刘亚光,等.系统性红斑狼疮患者淋巴细胞凋亡的研究.中华皮肤科杂志,1998,31:6-8. [8] Mohan C, Datta SK. Lupus: key pathogenic mechanisms and contributing factors. Clin Immunol Immunopathol, 1995,77:209-220. |